Get 40% Off
Is NVDA a 🟢 buy or 🔴 sell?Unlock Now

Recursion Pharmaceuticals Inc (RXRX)

NASDAQ
Currency in USD
Disclaimer
15.52
+0.76(+5.15%)
Closed
After Hours
13.05-2.47(-15.91%)
Unusual Post-Market activity
Day's Range
14.8215.74
52 wk Range
4.5416.75
Prev. Close
14.76
Open
15.46
Day's Range
14.82-15.74
52 wk Range
4.54-16.75
Volume
11,075,535
Average Volume (3m)
6,378,806
1-Year Change
101.04%
Shares Outstanding
216,623,241
Fair Value
Unlock
Dividends Payment Streak
Unlock
Analysts
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
12.33
Downside -20.55%

People Also Watch

4.80
ACHR
-2.44%
60.63
APP
+2.78%
11.61
NNOX
+21.83%
33.78
IOT
+0.87%
1.540
DNA
+10.00%
How do you feel today about RXRX?
Vote to see community's results!
or

Recursion Pharmaceuticals Inc Company Profile

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company. The Company is focused on utilizing advanced technologies in biology, chemistry, automation, and computer science to discover and design therapeutics. The Company’s platform, Recursion Operating System (OS), is built with diverse technologies and enables the Company to map and navigate trillions of biological and chemical relationships within the Recursion Data Universe. It integrates physical and digital components as iterative loops of atoms and bits of wet lab biology and chemistry data organized into virtuous cycles with computational tools to rapidly translate silico hypotheses into validated insights and novel chemistry. Its clinical programs include REC-994, REC-2282, REC-4881, and REC-3964. REC-994 is an orally bioavailable, superoxide, scavenger small molecule being developed for the treatment of cerebral cavernous malformation (CCM). REC-2282 is developed for the treatment of neurofibromatosis type 2.

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.